Our Take
Medicare Advantage insurers are using denial-and-appeal as a deliberate profit mechanism: block care first, reverse on appeal only when forced, extracting delay and friction as a feature.
Why it matters
This is not a compliance failure or a bug in AI evaluation. This is a business model. If the insurers themselves are overturning 97% of NaviHealth's denials, the initial denials were almost certainly intentional gatekeeping, not accuracy problems. Medicare beneficiaries and their doctors need to know the system is rigged against them by design.
Do this week
Medicare plan administrators: audit your NaviHealth denial-reversal ratio this week so you can document whether denials correlate with appeal likelihood rather than clinical need.
Medicare Advantage insurers weaponized AI denials for profit
The U.S. Office of Inspector General for the Department of Health and Human Services investigated how major Medicare Advantage plans, including UnitedHealth Group and Humana, handle requests for rehabilitative care. The investigators found that these insurers rely on NaviHealth, a UnitedHealth subsidiary that uses artificial intelligence to evaluate whether patients need nursing home care, physical therapy, and other post-acute services.
The pattern is stark: when patients appealed denials of nursing home care, the insurers overturned NaviHealth's decisions 97% of the time (per the OIG report). This is not a small margin of error. A 97% reversal rate on appeal signals that the initial denials were rarely clinically sound. They were gatekeeping.
The OIG's finding confirms a 2023 STAT investigation that documented how NaviHealth's denials led to poor outcomes for seriously ill patients. But this federal report adds a critical detail: the insurers themselves appear to have concluded that NaviHealth's denials don't hold up. If they knew that, they deployed the tool anyway.
Denial as business strategy, not medical necessity
Medicare Advantage plans profit by reducing payouts. Denying care that will likely be overturned on appeal creates three financial wins for the insurer: it delays payment (cash flow advantage), it discourages some patients from appealing (those too frail or confused to navigate the system), and it shifts the burden of proof onto beneficiaries and their doctors.
This is not a side effect of AI. This is the intended use case. The AI tool, NaviHealth, is working exactly as the business model requires: block first, lose on appeal only when the patient or doctor has the energy and knowledge to fight.
The beneficiaries affected are Medicare patients 65 and older, many already dealing with serious illness or injury. They are the least positioned to mount a sustained appeal. The doctors recommending care are forced into a second negotiation they should not need to have.
What to do now
If you manage a Medicare Advantage plan or oversee NaviHealth deployment, compare your denial rate to your appeal-reversal rate. A 97% reversal rate is not an outlier. It is likely the industry baseline. If your rate is lower, you may be denying care appropriately. If it is higher, you are denying care as a profit mechanism.
Physicians treating Medicare patients should assume their rehab requests will be denied on first submission. File the appeal immediately. Do not delay patient discharge or recovery planning based on the initial decision.
Medicare beneficiaries and their advocates should know: a denial from NaviHealth is not a clinical judgment. It is a negotiation tactic. Appeal it. The insurer is counting on you not to.